Media Room

Molecular Insight is focused on critical unmet diagnostic and therapeutic needs of the prostate cancer patient. 

We are targeting the development of a proprietary small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a novel systemic radiotherapy for relapsed and metastatic prostate cancer.

If you would like to learn more about the Company, please call Corporate Communications at 617.492.5554.